Featured Research

from universities, journals, and other organizations

'Bystander' chronic infections thwart development of immune cell memory

Date:
May 15, 2014
Source:
Perelman School of Medicine at the University of Pennsylvania
Summary:
Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines for unrelated illnesses. Researchers have found that chronic bystander viral or parasitic infections impaired the development of memory T cells in mouse models of long-term infection and in immune cells of people chronic hepatitis C infection.

Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines for unrelated illnesses. The underlying mechanisms for that impairment, however, are unclear, and distinguishing these so-called "bystander" effects on priming the immune system to fight future assaults versus development of immunological memory has been challenging.

A team from the Perelman School of Medicine at the University of Pennsylvania found that chronic bystander viral or parasitic infections -- which are models for human infections like hepatitis, malaria, and parasitic worms -- impaired the development of memory T cells in mouse models of long-term infection.

The effect of bystander infections also extended beyond mice. The researchers generated signatures of transcribed genes of cytomegalovirus-specific T cells from people with chronic hepatitis C infection and healthy controls. The gene-expression profiles of these two groups showed a clear impact of bystander chronic infection on T cells, including a difference in expression of many key T-cell memory-related genes. The findings are published this week in Immunity.

"Co-infections can result in poor immunity for other invading microbes and also vaccines," says senior author E. John Wherry, PhD, director, Institute for Immunology and associate professor of Microbiology. "We now understand one of the main reasons: failure to develop immune memory capable of responding upon new infections."

Immune memory, the hallmark of protective immunity against intracellular pathogens, is what keeps humans from being reinfected by a microbe to which they have already been exposed. Some immune cells are long-lived and active against whatever they were originally triggered by.

"If a person in the developing world gets a vaccine, and they harbor unrelated infections, such as malaria, tuberculosis, hepatitis B or C, and other parasitic infections, will this person have effective immune memory to the vaccine?" asks Wherry. "Our study has major relevance for applying vaccines in the developing world where co-infections might radically alter the type and quality of immunity generated by vaccines."

Wherry cites vaccine campaigns for rotavirus and polio virus in the developing world in which people who were vaccinated had only 50 percent efficacy compared to 80 to 90 percent in the developed world for the same vaccine. Vaccine efficacy is the incidence of people who are vaccinated and get disease versus an unvaccinated control group.

The effects of bystander infection on immune memory cell development seen in the current study were independent of initial priming of the immune system by other pathogens and were associated with a molecular signature of chronic inflammation. Chronic inflammation reduced the number of bystander T cells, their memory development, and their ability to protect from a challenge infection.

The team concluded that exposure to prolonged bystander inflammation impairs the transition of effector T cells to memory T cells. In other words, bystander chronic infections prevent the critical ability of the immune response to "stand down" and preserve responsive cells for future encounters with the same infection.

These data have important implications for vaccines for the developing world where co-infections are common and also for vaccines and immune therapies in patients with chronic inflammatory diseases. Specifically, working to treat co-infections -- via anti-parasite treatment in developing countries, for example -- prior to vaccines or treatment with anti-inflammatory agents at the right times may improve long-term immunity in some settings.


Story Source:

The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length.


Journal Reference:

  1. Erietta Stelekati, Haina Shin, TravisA. Doering, DouglasV. Dolfi, CarlyG. Ziegler, DanielP. Beiting, Lucas Dawson, Jennifer Liboon, David Wolski, Mohammed-AlkhatimA. Ali, PeterD. Katsikis, Hao Shen, DavidS. Roos, W.Nicholas Haining, GeorgM. Lauer, E.John Wherry. Bystander Chronic Infection Negatively Impacts Development of CD8 T Cell Memory. Immunity, 2014; 40 (5): 801 DOI: 10.1016/j.immuni.2014.04.010

Cite This Page:

Perelman School of Medicine at the University of Pennsylvania. "'Bystander' chronic infections thwart development of immune cell memory." ScienceDaily. ScienceDaily, 15 May 2014. <www.sciencedaily.com/releases/2014/05/140515132056.htm>.
Perelman School of Medicine at the University of Pennsylvania. (2014, May 15). 'Bystander' chronic infections thwart development of immune cell memory. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2014/05/140515132056.htm
Perelman School of Medicine at the University of Pennsylvania. "'Bystander' chronic infections thwart development of immune cell memory." ScienceDaily. www.sciencedaily.com/releases/2014/05/140515132056.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins